EN

Mark Leung

Partner

My practice focuses on corporate finance transactions, equity capital markets transactions, mergers and acquisitions and other corporate and commercial matters.

phone
+852 2841 6907
|
+852 9136 1283
mail
[email protected]

 

My experience includes advising companies, private equity firms and other financial institutions on cross-border and domestic mergers and acquisitions, joint ventures, growth capital and co-investments, convertible debt and other private equity transactions. I also have extensive experience in advising issuers and underwriters on initial public offerings in Hong Kong.

I am fluent in English, Cantonese and Mandarin.

 

Career Highlights

While a majority of the work undertaken by me is confidential, some publicly reported transactions include:

  • Advised Sinomax Group Limited (1418.HK), on its EUR 11 million initial and follow-on investments in a company incorporated in Denmark which engages in research and development, design, procurement and trading of sleeping products, furniture and home accessories in Europe.
  • Advised Inteluck, a technology-driven supply chain solutions provider in Southeast Asia, on its US$34 million financing led by Navegar.
  • Advised Beijing Saimo Technology Co., Ltd. (2571.HK), a developer of simulation testing solutions for intelligent connected vehicles, on its HK$433.0 million H-share listing on the Main Board of the Hong Kong Stock Exchange.
  • Advised BOCOM International (Asia) Limited in relation to the HK$758.0 million H-share listing of Shanghai Kindly Medical Instruments Co., Ltd. (1501.HK) on the Main Board of the Hong Kong Stock Exchange.
  • Advised Shanghai Haohai Biological Technology Co. Ltd. (6826.HK), a biomedical materials manufacturer, in relation to its US$300.0 million H-share listing on the Main Board of the Hong Kong Stock Exchange.
  • Advised Tapestry, Inc. (formerly Coach, Inc.) on its withdrawal of listing of its depositary receipts from the Hong Kong Stock Exchange.